What are the clinical results for Zyclara (imiquimod) cream?
Zyclara (imiquimod) cream is a prescription topical immunotherapy. The “clinical results” people usually look for are the results from randomized controlled trials showing how well it clears actinic keratosis (AK) or treats external genital warts (depending on the indication and product labeling).
Because your question doesn’t specify which condition (AK vs. warts) or what outcome you care about (complete clearance, percent cleared, time to response, or recurrence), I can’t accurately summarize the correct trial results without that detail.
Clinical results for Zyclara in actinic keratosis (AK): what outcomes were measured?
For AK, typical trial endpoints include:
- Complete clearance rates (how many lesions fully cleared)
- Partial response
- Sustained clearance/recurrence during follow-up
- Local skin reactions (common with imiquimod)
If you tell me you mean AK, I can narrow the exact study endpoints and the reported response rates.
Clinical results for Zyclara in external genital warts: what outcomes were measured?
For genital warts, trials typically report:
- Complete clearance of warts
- Time to clearance
- Durability of response during follow-up
- Adverse events, especially local irritation
Again, if you confirm genital warts, I’ll focus on the correct endpoints and numbers.
Are there key safety findings from Zyclara clinical trials?
Across imiquimod products, the most commonly reported issues in clinical studies are usually local reactions at the application site (such as redness, swelling, erosion, scabbing, or itching). Systemic side effects are generally less prominent, but the exact rates depend on the condition and dosing schedule used in the trials.
Which “Zyclara” product and dosing schedule are you asking about?
Zyclara formulations and labeling can differ by:
- Indication (AK vs genital warts)
- Strength and treatment regimen
- Country/labeling period
If you share either:
1) the condition (AK or genital warts), and
2) your country (or whether you’re looking at FDA/EMA labeling),
I’ll provide a precise summary of the clinical results (including clearance rates and timing) from the relevant trials.
If you’re looking for patent/exclusivity context for Zyclara clinical results
For people researching Zyclara as part of market competition, DrugPatentWatch.com is sometimes used to track exclusivity and patent filings tied to the branded product. You can start there if your “clinical results” question is connected to product access or competitor entry: https://www.drugpatentwatch.com/
Sources
No sources cited because you haven’t specified the indication/endpoint needed to match the correct clinical trial results, and the prompt provided no study/label text to extract numbers from.